$28.78
0.77%
Nasdaq, Jan 02, 10:04 pm CET

Quidel Corporation Stock price

$28.78
+2.25 8.48% 1M
-1.40 4.64% 6M
+0.22 0.77% YTD
-16.26 36.10% 1Y
-56.89 66.41% 3Y
-161.50 84.87% 5Y
+8.73 43.54% 10Y
+18.02 167.47% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.22 0.77%

New AI Insights on Quidel Corporation Insights AI Insights on Quidel Corporation

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$2.0b
Enterprise Value
$4.5b
Net debt
$2.6b
Cash
$98.1m
Shares outstanding
67.9m
Valuation (TTM | estimate)
P/E
negative | 13.3
P/S
0.7 | 0.7
EV/Sales
1.7 | 1.6
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
46.5%
Return on Equity
-68.8%
ROCE
2.2%
ROIC
2.2%
Debt/Equity
1.3
Financials (TTM | estimate)
Revenue
$2.7b | $2.8b
EBITDA
$299.7m | $606.0m
EBIT
$108.1m | $390.6m
Net Income
$-1.2b | $147.2m
Free Cash Flow
$-152.6m
Growth (TTM | estimate)
Revenue
-3.7% | -0.7%
EBITDA
-3.5% | 143.2%
EBIT
4.3% | 752.8%
Net Income
36.8% | 107.2%
Free Cash Flow
-57.0%
Margin (TTM | estimate)
Gross
47.2%
EBITDA
11.0% | 21.9%
EBIT
4.0%
Net
-43.4% | 5.3%
Free Cash Flow
-5.6%
More
EPS
$-17.3
FCF per Share
$-2.2
Short interest
27.7%
Employees
7k
Rev per Employee
$420.0k
Show more

Is Quidel Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Quidel Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Quidel Corporation forecast:

8x Buy
57%
5x Hold
36%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Quidel Corporation forecast:

Buy
57%
Hold
36%
Sell
7%

Financial data from Quidel Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,714 2,714
4% 4%
100%
- Direct Costs 1,435 1,435
3% 3%
53%
1,280 1,280
5% 5%
47%
- Selling and Administrative Expenses 740 740
3% 3%
27%
- Research and Development Expense 188 188
19% 19%
7%
300 300
3% 3%
11%
- Depreciation and Amortization 192 192
7% 7%
7%
EBIT (Operating Income) EBIT 108 108
4% 4%
4%
Net Profit -1,179 -1,179
37% 37%
-43%

In millions USD.

Don't miss a Thing! We will send you all news about Quidel Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quidel Corporation Stock News

Neutral
PRNewsWire
17 days ago
SAN DIEGO , Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jonathan Siegrist, PhD, Executive Vice President of Research & Development and Chief Technology Officer at QuidelOrtho. Dr. Siegrist is a recognized leader in molecular diagnostics and biomedical engineering, d...
Positive
The Motley Fool
28 days ago
New York City-based Newtyn Management bought 994,332 shares of QuidelOrtho Corporation in the third quarter, increasing its position by an estimated $30.4 million. At quarter-end, the firm reported holding 2.7 million QDEL shares valued at $79.5 million.
Neutral
Seeking Alpha
about one month ago
QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
More Quidel Corporation News

Company Profile

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Head office United States
CEO Brian Blaser
Employees 6,600
Founded 2022
Website www.quidelortho.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today